Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards the Most Accurate Diagnosis and Monitoring of Complement-mediated Rare Kidney Diseases

NCT05985122 is registered in ClinicalTrials.gov with Mario Negri Institute for Pharmacological Research as lead sponsor.

NCT NCT05985122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05985122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards the Most Accurate Diagnosis and Monitoring of Complement-mediated Rare Kidney Diseases
Lead sponsor
Mario Negri Institute for Pharmacological Research
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 1, 2023
Completion date
October 31, 2026
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, hemolytic-uremic syndrome, membranoproliferative glomerulonephritis